Guided Therapeutics (GTHP) Return on Sales Growth (3y) (2013 - 2025)
Guided Therapeutics (GTHP) Return on Sales Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 332.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 332.00 |
| Sep 30, 2025 | 355.00 |
| Jun 30, 2025 | 178.00 |
| Mar 31, 2025 | -2,341.00 |
| Dec 31, 2024 | -645.00 |
| Sep 30, 2024 | -60.00 |
| Jun 30, 2024 | 460.00 |
| Mar 31, 2024 | -32.00 |
| Dec 31, 2023 | -99.00 |
| Sep 30, 2023 | -95.00 |
| Jun 30, 2023 | 145.00 |
| Mar 31, 2023 | -96.00 |
| Dec 31, 2022 | -402.00 |
| Sep 30, 2022 | -241.00 |
| Jun 30, 2022 | 2,478.00 |
| Mar 31, 2022 | -89.00 |
| Dec 31, 2021 | 58.00 |
| Sep 30, 2021 | 377.00 |
| Jun 30, 2021 | -944.00 |
| Mar 31, 2021 | -305.00 |